Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Trenkwalder

Showing results (91-100 of 141) with videos related to

Pageof 15
Sort By:
Neurology|March 1, 1992
123I-iodobenzamide-SPECT predicts dopaminergic responsiveness in patients with de novo parkinsonismJ Schwarz, K Tatsch, G Arnold, et al.
Neurology|December 1, 1993
123I-iodobenzamide-SPECT in 83 patients with de novo parkinsonismJ Schwarz, K Tatsch, G Arnold, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 22, 2006
Selective reduction of amyloid beta42 discriminates Alzheimer's disease from Huntington's disease: indication for distinct pathological events in amyloid beta peptide aggregationB Mollenhauer, M Bibl, H Esselmann, et al.
Der Nervenarzt|December 1, 1995
[Effectiveness of slow release L-DOPA/benserazide in treatment of end-of-dose akinesia in Parkinson disease]T E Eichhorn, A Schrag, C Trenkwalder, et al.
European Journal of Neurology|October 12, 2020
Socioeconomic impact of restless legs syndrome and inadequate restless legs syndrome management across European settingsC Trenkwalder, M Tinelli, G K Sakkas, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 12, 2002
Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parametersP Flachenecker, T Kümpfel, B Kallmann, et al.
Der Nervenarzt|April 11, 2009
[Depression in restless legs syndrome. Pathogenesis, assessment, and implications for treatment]M Hornyak, H Benes, I Eisensehr, et al.
European Journal of Neurology|September 22, 2006
EFNS guidelines on management of restless legs syndrome and periodic limb movement disorder in sleepL Vignatelli, M Billiard, P Clarenbach, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1992
Marked reduction of striatal dopamine D2 receptors as detected by 123IBZM-SPECT in a Wilson's disease patient with generalized dystoniaJ Schwarz, K Tatsch, T Vogl, et al.
Neurology|June 15, 2000
Prognosis with Parkinson's disease in europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research GroupK Berger, M M Breteler, C Helmer, et al.
Pageof 15

Showing results (91-100 of 141) with videos related to

Sort By:
Pageof 15
Neurology|March 1, 1992
123I-iodobenzamide-SPECT predicts dopaminergic responsiveness in patients with de novo parkinsonismJ Schwarz, K Tatsch, G Arnold, et al.
Neurology|December 1, 1993
123I-iodobenzamide-SPECT in 83 patients with de novo parkinsonismJ Schwarz, K Tatsch, G Arnold, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 22, 2006
Selective reduction of amyloid beta42 discriminates Alzheimer's disease from Huntington's disease: indication for distinct pathological events in amyloid beta peptide aggregationB Mollenhauer, M Bibl, H Esselmann, et al.
Der Nervenarzt|December 1, 1995
[Effectiveness of slow release L-DOPA/benserazide in treatment of end-of-dose akinesia in Parkinson disease]T E Eichhorn, A Schrag, C Trenkwalder, et al.
European Journal of Neurology|October 12, 2020
Socioeconomic impact of restless legs syndrome and inadequate restless legs syndrome management across European settingsC Trenkwalder, M Tinelli, G K Sakkas, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 12, 2002
Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parametersP Flachenecker, T Kümpfel, B Kallmann, et al.
Der Nervenarzt|April 11, 2009
[Depression in restless legs syndrome. Pathogenesis, assessment, and implications for treatment]M Hornyak, H Benes, I Eisensehr, et al.
European Journal of Neurology|September 22, 2006
EFNS guidelines on management of restless legs syndrome and periodic limb movement disorder in sleepL Vignatelli, M Billiard, P Clarenbach, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1992
Marked reduction of striatal dopamine D2 receptors as detected by 123IBZM-SPECT in a Wilson's disease patient with generalized dystoniaJ Schwarz, K Tatsch, T Vogl, et al.
Neurology|June 15, 2000
Prognosis with Parkinson's disease in europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research GroupK Berger, M M Breteler, C Helmer, et al.
Pageof 15